Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction

被引:27
|
作者
Li, Chong [1 ]
Zhan, Changyou [2 ,3 ]
Zhao, Le [2 ,3 ]
Chen, Xishan [4 ,5 ]
Lu, Wei-Yue [4 ,5 ]
Lu, Wuyuan [2 ,3 ,4 ,5 ]
机构
[1] Southwest Univ, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China
[2] Univ Maryland Sch Med, Inst Human Virol, Baltimore, MD 21201 USA
[3] Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
[4] Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
[5] Fudan Univ Sch Pharm, PLA, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金; 美国国家卫生研究院;
关键词
Retro-inverso peptide; p53; MDM2; MDMX; D-Peptide; Apamin; Stingin; D-PEPTIDE INHIBITORS; P53; PATHWAY; AFFINITY; MDM2; ACTIVATION; DESIGN; ENANTIOMERS; MIMICRY;
D O I
10.1016/j.bmc.2013.04.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide retro-inverso isomerization is thought to be functionally neutral and has been widely used as a tool for designing proteolytically stable D-isomers to recapitulate biological activities of their parent L-peptides. Despite success in a wide range of applications, exceptions amply exist that clearly defy this rule of thumb when parent L-peptides adopt an a-helical conformation in their bound state. The detrimental energetic effect of retro-inverso isomerization of an a-helical L-peptide on its target protein binding has been estimated to be 3.0-3.4 kcal/mol. To better understand how the retro-inverso isomer of a structured protein works at the molecular level, we chemically synthesized and functionally characterized the retro-inverso isomer of a rationally designed miniature protein termed stingin of 18 amino acid residues, which adopts an N-terminal loop and a C-terminal alpha-helix stabilized by two intra-molecular disulfide bridges. Stingin emulated the transactivation peptide of the p53 tumor suppressor protein and bound with high affinity and via its C-terminal a-helix to MDM2 and MDMX-the two negative regulators of p53. We also prepared the retro isomer and D-enantiomer of stingin for comparative functional studies using fluorescence polarization and surface plasmon resonance techniques. We found that retro-inverso isomerization of L-stingin weakened its MDM2 binding by 720 fold (3.9 kcal/mol); while enantiomerization of L-stingin drastically reduced its binding to MDM2 by three orders of magnitude, sequence reversal completely abolished it. Our findings demonstrate the limitation of peptide retro-inverso isomerization in molecular mimicry and reinforce the notion that the strategy works poorly with biologically active a-helical peptides due to inherent differences at the secondary and tertiary structural levels between an L.-peptide and its retro-inverso isomer despite their similar side chain topologies at the primary structural level) (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4045 / 4050
页数:6
相关论文
共 50 条
  • [1] Discovery of a new inhibitor of p53-MDM2 interaction using yeast
    Soares, Joana
    Leao, M.
    Pereira, Clara
    Bisio, Alessandra
    Ciribilli, Yari
    Paiva, Ana
    Sousa, Emilia
    Pinto, Madalena
    Inga, Alberto
    Saraiva, Lucilia
    YEAST, 2013, 30 : 200 - 200
  • [2] The p53-MDM2 interaction in adult medulloblastomas
    Giordana, MT
    Schiffer, P
    Boghi, A
    Pradotto, L
    Morra, I
    Mauro, A
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 447 - 447
  • [3] Inhibition of p53-Mdm2 Interaction by Ellagitannins
    Tatsuda, D.
    Umezawa, Y.
    Iijima, M.
    Momose, I.
    Nomoto, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 66 - 66
  • [4] Inhibition of the p53-MDM2 interaction:: Targeting a protein-protein interface
    Chène, P
    MOLECULAR CANCER RESEARCH, 2004, 2 (01) : 20 - 28
  • [5] A Fluorescent Probe for Imaging p53-MDM2 Protein-Protein Interaction
    Liu, Zhenzhen
    Miao, Zhenyuan
    Li, Jin
    Fang, Kun
    Zhuang, Chunlin
    Du, Lupei
    Sheng, Chunquan
    Li, Minyong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (04) : 411 - 417
  • [6] Small molecule protein-protein inhibitors for the p53-MDM2 interaction
    Dudkina, Anna S.
    Lindsley, Craig W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 952 - 960
  • [7] Targeting the p53-MDM2 interaction to treat cancer
    Klein, C
    Vassilev, LT
    BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1415 - 1419
  • [8] Towards cellular permeability for a peptide interfering with the p53-MDM2 protein interaction
    Stigter, E. A.
    Chene, P.
    Ruetz, S.
    Brock, R.
    Vorherr, Th.
    BIOPOLYMERS, 2013, 100 (03) : 260 - 260
  • [9] Studies towards the synthesis of the p53-MDM2 inhibitor chlorofusin
    Germain, Andrew R.
    Porco, John A., Jr.
    Searcey, Mark
    Woon, Esther
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [10] Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction
    Beloglazkina, Anastasia
    Zyk, Nikolai
    Majouga, Alexander
    Beloglazkina, Elena
    MOLECULES, 2020, 25 (05):